BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.22 0.1  2.2%

Last Trade - 12/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £225.8m
Enterprise Value £198.9m
Revenue £113.3m
Position in Universe 4062nd / 6856

BRIEF-Endo and Biodelivery Sciences announce acceptance of nda for Belbuca buccal film for chronic pain

Mon 23rd February, 2015 12:31pm
Feb 23 (Reuters) - Endo International PLC  ENDP.O : 
 * Endo pharmaceuticals and Biodelivery Sciences announce acceptance of nda for 
   Belbuca(TM) (buprenorphine hcl) buccal film for the management of chronic 
   pain 
 * FDA has accepted the new drug application (nda) for the companies' belbuca 
   (buprenorphine hcl) buccal film 
 * Says FDA has indicated standard review designation for nda and therefore 
   action date is expected 10 months from the nda submission 
 
* Source text for Eikon  ID:nPreX0T6Ga  
 
* Further company coverage  ENDP.O  ((Bengaluru Newsroom; +1 646 223 8780))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.